​

Surgery Partners (SGRY) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

SGRY Stock Forecast

Surgery Partners (SGRY) stock forecast, based on 21 Wall Street analysts, predicts a 12-month average price target of $35.50, with a high of $40.00 and a low of $31.00. This represents a 67.30% increase from the last price of $21.22.

$20 $24 $28 $32 $36 $40 High: $40 Avg: $35.5 Low: $31 Last Closed Price: $21.22

SGRY Stock Rating

Surgery Partners stock's rating consensus is Buy, based on 21 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 14 Buy (66.67%), 7 Hold (33.33%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 21 7 14 0 Strong Sell Sell Hold Buy Strong Buy

SGRY Price Target Upside V Benchmarks

TypeNameUpside
StockSurgery Partners67.30%
SectorHealthcare Stocks 35.25%
IndustryMedical Care Facilities Stocks23.83%

Price Target Trends

1M3M12M
# Anlaysts--4
Avg Price Target--$35.00
Last Closing Price$21.22$21.22$21.22
Upside/Downside--64.94%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25183--12
Mar, 25183--12
Feb, 25183--12
Jan, 25293--14
Dec, 24283--13
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 13, 2024Brian TanquilutJefferies$40.00$29.7434.50%88.50%
Nov 13, 2024Andrew MokBarclays$31.00$29.744.24%46.09%
Oct 14, 2024AJ RiceUBS$38.00$30.4624.75%79.08%
Jun 28, 2024Tao QiuMacquarie$31.00$24.3227.47%46.09%
May 04, 2022Citigroup$64.00$53.6219.36%201.60%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 14, 2024Cowen & Co.BuyBuyhold
Nov 13, 2024JefferiesBuyBuyhold
Oct 14, 2024UBSBuyinitialise
Oct 10, 2024KeyBancSector Weightinitialise
Oct 04, 2024RBC CapitalBuyBuyhold
Aug 19, 2024Raymond JamesUnderperformUnderperformhold
Jun 28, 2024MacquarieBuyBuyhold
Jun 28, 2024MacquarieOutperforminitialise
Mar 05, 2024RBC CapitalBuyBuyhold
Nov 14, 2023Cowen & Co.Outperformupgrade

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$0.03$0.98$0.95$-0.09$-1.33---
Avg Forecast$-1.29$-0.15$0.11$0.93$0.85$0.96$1.21$1.75
High Forecast$-1.28$-0.15$0.12$0.96$0.98$1.17$1.35$1.78
Low Forecast$-1.31$-0.15$0.11$0.89$0.76$0.72$0.95$1.73
Surprise %-102.33%-753.33%763.64%-109.68%-256.47%---

Revenue Forecast

$2B $2B $3B $3B $4B $5B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$1.86B$2.23B$2.54B$2.74B$3.11B---
Avg Forecast$1.86B$2.24B$2.52B$2.75B$3.08B$3.39B$3.70B$4.12B
High Forecast$1.88B$2.26B$2.55B$2.79B$3.12B$3.44B$3.70B$4.18B
Low Forecast$1.84B$2.22B$2.50B$2.72B$3.07B$3.36B$3.70B$4.08B
Surprise %-0.02%-0.59%0.75%-0.24%1.19%---

Net Income Forecast

$-200M $-110M $-20M $70M $160M $250M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$1.30M$70.70M$87.00M$-11.90M$-168.10M---
Avg Forecast$-162.60M$-86.91M$-58.15M$-11.90M$109.27M$118.76M$134.00M$220.40M
High Forecast$-160.65M$-69.53M$-42.53M$-8.70M$123.37M$147.04M$169.40M$223.98M
Low Forecast$-164.70M$-104.29M$-73.77M$-15.10M$95.17M$90.48M$118.74M$216.82M
Surprise %-100.80%-181.35%-249.61%--253.84%---

SGRY Forecast FAQ

Is Surgery Partners stock a buy?

Surgery Partners stock has a consensus rating of Buy, based on 21 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 14 Buy, 7 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Surgery Partners is a favorable investment for most analysts.

What is Surgery Partners's price target?

Surgery Partners's price target, set by 21 Wall Street analysts, averages $35.5 over the next 12 months. The price target range spans from $31 at the low end to $40 at the high end, suggesting a potential 67.30% change from the previous closing price of $21.22.

How does Surgery Partners stock forecast compare to its benchmarks?

Surgery Partners's stock forecast shows a 67.30% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the medical care facilities stocks industry (23.83%).

What is the breakdown of analyst ratings for Surgery Partners over the past three months?

  • April 2025: 8.33% Strong Buy, 66.67% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 8.33% Strong Buy, 66.67% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 8.33% Strong Buy, 66.67% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.

What is Surgery Partners’s EPS forecast?

Surgery Partners's average annual EPS forecast for its fiscal year ending in December 2025 is $0.96, marking a -172.18% decrease from the reported $-1.33 in 2024. Estimates for the following years are $1.21 in 2026, and $1.75 in 2027.

What is Surgery Partners’s revenue forecast?

Surgery Partners's average annual revenue forecast for its fiscal year ending in December 2025 is $3.39B, reflecting a 8.75% increase from the reported $3.11B in 2024. The forecast for 2026 is $3.7B, and $4.12B for 2027.

What is Surgery Partners’s net income forecast?

Surgery Partners's net income forecast for the fiscal year ending in December 2025 stands at $118.76M, representing a -170.65% decrease from the reported $-168M in 2024. Projections indicate $134M in 2026, and $220.4M in 2027.